Kao, Kung-Chi http://orcid.org/0000-0002-5756-6684
Vilbois, Stefania
Tsai, Chin-Hsien http://orcid.org/0000-0001-5278-2321
Ho, Ping-Chih http://orcid.org/0000-0003-3078-3774
Article History
Received: 12 July 2021
Accepted: 29 August 2022
First Online: 13 October 2022
Competing interests
: P.-C.H. serves as a scientific advisor for Elixiron Immunotherapeutics and is a founder of Pilatus Biosciences. C.-H.T. receives research support from Elixiron Immunotherapeutics. The other authors declare no competing interests.